Cargando…
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
Facioscapulohumeral muscular dystrophy (FSHD) is a prevalent, incurable myopathy, linked to hypomethylation of D4Z4 repeats on chromosome 4q causing expression of the DUX4 transcription factor. However, DUX4 is difficult to detect in FSHD muscle biopsies and it is debatable how robust changes in DUX...
Autores principales: | Banerji, Christopher R. S., Panamarova, Maryna, Hebaishi, Husam, White, Robert B., Relaix, Frédéric, Severini, Simone, Zammit, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735185/ https://www.ncbi.nlm.nih.gov/pubmed/29255294 http://dx.doi.org/10.1038/s41467-017-01200-4 |
Ejemplares similares
-
Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2019) -
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
por: Banerji, Christopher R S, et al.
Publicado: (2021) -
Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity
por: Banerji, Christopher R S, et al.
Publicado: (2020) -
The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023) -
Cellular and animal models for facioscapulohumeral muscular dystrophy
por: DeSimone, Alec M., et al.
Publicado: (2020)